- Report
- February 2022
- 97 Pages
Global
From €738EUR$760USD£637GBP
€923EUR$950USD£796GBP
- Report
- February 2023
- 144 Pages
Global
From €5342EUR$5,500USD£4,608GBP
- Report
- April 2022
- 307 Pages
Global
From €5391EUR$5,550USD£4,650GBP
- Report
- February 2020
- 225 Pages
Global
From €3093EUR$3,185USD£2,669GBP
€4419EUR$4,550USD£3,812GBP
- Report
- April 2023
- 111 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- August 2022
- 138 Pages
Global
From €4371EUR$4,500USD£3,770GBP
- Report
- March 2023
- 209 Pages
Global
From €3093EUR$3,185USD£2,669GBP
€4419EUR$4,550USD£3,812GBP
- Report
- February 2021
Global
From €3093EUR$3,185USD£2,669GBP
€4419EUR$4,550USD£3,812GBP
- Report
- August 2022
- 116 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- August 2020
- 111 Pages
Global
From €4128EUR$4,250USD£3,561GBP
- Report
- June 2021
- 102 Pages
Global
€21368EUR$22,000USD£18,433GBP
- Report
- October 2022
- 232 Pages
Global
From €3497EUR$3,600USD£3,016GBP
- Report
- July 2021
- 112 Pages
Global
From €3200EUR$3,529USD£2,857GBP
- Report
- February 2024
- 112 Pages
Global
From €3500EUR$3,860USD£3,125GBP
- Report
- February 2020
- 40 Pages
South Korea
From €2520EUR$2,595USD£2,174GBP
- Report
- February 2020
- 40 Pages
Japan
From €2520EUR$2,595USD£2,174GBP
- Report
- May 2023
- 458 Pages
Global
From €5565EUR$5,730USD£4,801GBP
- Book
- April 2023
- 128 Pages
- Book
- November 2022
- 208 Pages
- Book
- December 2019
- 432 Pages
The Bleeding Disorder market is a subset of the Hematology market, which focuses on the diagnosis, treatment, and prevention of blood-related diseases. Bleeding Disorders are a group of conditions that affect the body's ability to control bleeding. These disorders can be caused by a variety of factors, including genetic mutations, acquired conditions, and environmental factors. Common bleeding disorders include hemophilia, von Willebrand disease, and platelet disorders. Treatment for these disorders typically involves the use of clotting factor concentrates, antifibrinolytic agents, and other medications.
The Bleeding Disorder market is highly competitive, with a number of companies offering products and services to treat these conditions. Some of the major players in the market include Novo Nordisk, Pfizer, Bayer, CSL Behring, and Shire. Show Less Read more